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Abstract 
Despite high levels of use, the mechanism of action of effective pharmacotherapies in 
Attention Deficit Hyperactivity Disorder (ADHD) is unknown. It has recently been 
hypothesized that one site of therapeutic action is the midbrain superior colliculus, a 
structure traditionally associated with visual processing, but also strongly implicated 
in distractibility, a core symptom of ADHD. We used male juvenile Wistar rats to 
examine the effects of therapeutically relevant doses of methylphenidate and d-
amphetamine on collicular activity in vitro. Here we report a novel shared mechanism 
of the two drugs whereby they enhance the signal to noise ratio in the superior 
colliculus. The effects on the signal to noise ratio were mediated by serotonin via a 
pre-synaptic mechanism. This modulatory action would bias the system towards 
salient events and lead to an overall decrease in distractibility.  
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Attention Deficit Hyperactivity Disorder (ADHD) is the most common neuro-
developmental disorder affecting an estimated 8-12% of children (Biederman & 
Faraone, 2005), with symptoms often persisting into adulthood (Spencer et al., 2002). 
Nonetheless, the pathophysiological changes which underlie ADHD are far from 
completely understood (Biederman, 2005), as are the mechanisms of action of the 
most commonly used pharmacotherapies – amphetamines and methylphenidate 
(Spencer et al., 2002). A central component of ADHD is an increase in distractibility 
(Douglas, 1983; Thorley, 1984) and amphetamine has been found to be effective in 
reducing distractibility in ADHD (Brown & Cooke, 1994; Spencer et al., 2001) and in 
healthy subjects (Halliday et al., 1990; Agmo et al., 1997). Behavioural evidence 
suggests that distractibility is intimately linked with the superior colliculus (SC), a 
major component of the subcortical visual system that is highly conserved across 
species (Overton et al., 1985). Work in a range of species has shown that collicular 
lesions lead to a decrease in distractibility (Goodale et al., 1978; Milner et al., 1978) 
Conversely, removal of prefrontal cortex control of the colliculus leads to an increase 
in distractibility in humans (Gaymard et al., 2003). 
 
We have recently shown that d-amphetamine decreases multiunit and field potential 
responses to wholefield light flash stimuli in the superficial layers of the SC (Gowan 
et al., 2008). Hence, the SC may be a potential therapeutic target in ADHD, a 
proposal supported by an expanding body of evidence which suggests that the 
colliculus is dysfunctional in the disorder (Overton, 2008). However, our results are in 
contrast to earlier work in the cat (Grasse et al., 1993), where d-amphetamine 
enhanced single unit responses in the SC to stimuli presented within the excitatory 
region of the cells’ receptive fields. Since the receptive fields of superficial layer SC 
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have suppressive surrounds (McIlwain & Buser, 1968; Binns & Salt, 1997), 
wholefield light stimuli (Gowan et al., 2008) covering both centre and surround are 
sub-optimal, whereas stimuli confined to the excitatory centre (Grasse et al., 1993) are 
considerably more effective. This raises the intriguing possibility that d-amphetamine 
depresses responses to stimuli which give relatively low levels of collicular activation 
and enhances responses to stimuli which give relatively high levels of activation, thus 
increasing the signal-to-noise ratio. This novel possibility was explored in the present 
study using an in vitro preparation in which visual afferents to the superficial layers 
were electrically stimulated at a range of intensities, providing low and high levels of 
SC activation. The evoked responses were exposed to therapeutically relevant doses 
of both d-amphetamine and methylphenidate. 
 
Experimental Procedures 
All procedures conducted were performed with both Institutional ethical approval and 
Home Office approval under the Animals (Scientific Procedures) Act (1986). 
 
Slice Preparation: Juvenile male Wistar rats (Harlan Ltd., Bicester, UK), aged P20 to 
P35 (Andersen et al., 2008), were killed by decapitation under isoflurane anaesthesia 
(N=123). The brain was immediately placed in ice-cold 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) ringer containing (in mM): 120 NaCl, 5 KCl, 
20 NaHCO3, 6.7 HEPES acid, 3.3 HEPES salt, 2 CaCl2, 2 MgSO4, 1.2 KH2PO4  and 
10 glucose, saturated with 95% O2/5% CO2.  A coronal midbrain block was mounted 
onto a specimen plate with cyanoacrylate adhesive and placed in the slicing chamber 
submerged in HEPES ringer. 400ȝm coronal sections were prepared using a 
vibratome (VT1000S, Leica Microsystems Ltd., Milton Keynes, UK) and then 
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maintained at room temperature for one hour. Thirty minutes prior to recording, 
individual slices were transferred to a submersion recording chamber held at 34 °C, 
containing artificial cerebrospinal fluid (aCSF) circulating at 2 ml/min. The aCSF 
solution contained (in mM): 124 NaCl, 3.7 KCl, 26 NaHCO3, 2.4 CaCl2, 1.3 MgSO4, 
1.3 KH2PO4, and 10 glucose, saturated with 95% O2/5% CO2.   
 
Extracellular recording: Extracellular glass recording electrodes, broken back to give 
an impedance of 3-10 Mȍ, filled with aCSF and 2% Pontamine Sky Blue, were 
placed in the superficial grey layer of the SC, and field potential (fEPSP) responses 
were evoked with electrical stimulation of the afferent optic fibres in the optic tract 
with concentric bipolar stimulating electrodes (FHC, Bowdoinham, ME; Figure 1A). 
Stimulation was triggered using Signal software (Cambridge Electronic Design 
[CED], Cambridge, UK) and produced by an isolated output unit built in house.  
 
Data acquisition and analysis: Data were acquired and digitized at 20 KHz using a 
micro1401 acquisition system (CED) and stored directly on a computer for offline 
analysis. Field potentials were low pass filtered (dc-1 KHz) and amplified with a gain 
of 1000 (using a commercial amplifier [NeuroData Inc., Selden, NY] coupled to 
second amplifier and filter built in house). Stimulus-response curves were completed 
at the start of every experiment to calculate the intensity of the stimulation chosen 
relative to the intensity giving the maximum response. Baseline recordings (at a 
stimulation frequency of 0.033 Hz) were then made at the chosen intensity and 
assessed for stability (less than 10% variation of response amplitude over averages of 
5 pulses). Only when recordings were stable for at least 15 min were drugs applied. 
Stimulation continued throughout and drugs were present for at least 30 min prior to 
measurements being made. All drugs, once added, were continuously perfused for the 
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duration of the experiment. Only a single drug concentration (see below) and a single 
drug application was used per slice. For assessing the effects of drugs on responses, 
stimulation intensity and frequency were held constant, and averages of 15 min of 
stable recording (30 pulses) in the presence of the drug were compared to the stable 
15 min pre-drug period. Response sizes were determined by measuring the amplitude 
between the pre-stimulation baseline and trough.  
 
For paired pulse depression (PPD) experiments, an inter pulse interval of 500 ms was 
chosen, due to the extended duration of the response to each pulse and previous use of 
this inter pulse interval in other collicular work  (Platt & Withington, 1997). Paired 
pulse ratios were obtained by dividing the amplitude of the response to the second 
pulse by that of the first. For the analysis, stimulus intensities were grouped into high 
(t70% of the intensity required to elicit the maximal response), low (those elicited 
with a stimulation intensity d30% of the maximum) and medium (40-60% of the 
maximum).  
 
To quantify AMPA and NMDA receptor-mediated contributions to the elicited 
responses, responses in the presence of the NMDA receptor antagonist AP5 (10 ȝM) 
were subtracted from responses in the absence of AP5 to give the size of the NMDA 
component. The remaining response was then exposed to the AMPA receptor 
antagonist CNQX (10 ȝM) to allow calculation of the AMPA component. Statistical 
analyses were conducted using linear regression analysis, t-tests or one-way ANOVA 
and probabilities of p<0.05 (two tailed) were considered to be significant. 
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Drugs: All experiments were conducted in the presence of the GABAA receptor 
antagonist bicuculline methiodide (10 ȝM) in line with previous research (Isa et al., 
1998). The bicuculline was applied prior to any recordings and after the slice had at 
least 30 minutes to equilibrate in the recording chamber. A further 30 minutes elapsed 
in the presence of bicuculline before recordings were made. All drugs were dissolved 
in distilled water (except for metergoline, which was dissolved in DMSO), to make 
stock aliquots at 1000x final concentrations and stored at -20 °C until required. 
Methylphenidate hydrochloride and d-amphetamine sulphate were obtained from 
Sigma-Aldrich (Gillingham, UK). All other drugs were from Tocris Biosciences 
(Bristol, UK). Although our study used rat brain tissue, which is likely to be both 
pharmacokinetically and pharmacodynamically (with regard to receptor efficacies) 
different to human brain tissue, the doses of methylphenidate and d-amphetamine 
used were guided by those used therapeutically in humans. At doses administered 
therapeutically, plasma levels of methylphenidate can reach approximately 40 ng/ml 
(Greenhill et al., 2001) and d-amphetamine around 120 ng/ml (McGough et al., 2003; 
Ricaurte et al., 2005). Brain levels of these substances reach higher concentrations 
than those found in plasma. Indeed, brain concentrations can be around 8 times the 
plasma concentration (methylphenidate, Gal et al., 1977; d-amphetamine, Riffee et al., 
1978). Given these considerations, we chose concentrations of 100 ng/ml (0.37 ȝM; 
low), 200 ng/ml (0.74 ȝM; medium) and 300 ng/ml (1.11 ȝM; high) for 
methylphenidate and 300 ng/ml (1.63 ȝM; low), 600 ng/ml (3.26 ȝM; medium) and 
900 ng/ml (4.89 ȝM; high) for d-amphetamine. 
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Results 
D-Amphetamine and methylphenidate alter SC responsiveness in a stimulation 
intensity-dependent fashion 
The chosen stimulation intensities elicited a range of levels of SC activation: 
responses elicited by high intensities had significantly larger amplitudes than those 
elicited by low intensities (0.49±0.03 vs 0.25±0.04 mV respectively: (t[101] = 5.12, 
p<0.00001). The effects of d-amphetamine and methylphenidate on these responses 
were correlated with the intensity of the eliciting stimulus – a substantial number of 
responses elicited by low intensities were reduced in amplitude whilst those elicited 
by higher intensities were largely unaffected (Figure 1B and C; Supplementary Figure 
1). The relationship between stimulus intensity and drug effects was significant for all 
concentrations of d-amphetamine (900 ng/ml: R2=0.53, p<0.001; 600 ng/ml: R2=0.31, 
p<0.05; 300 ng/ml: R2=0.47, p<0.001) and methylphenidate (300 ng/ml: R2=0.35, 
p<0.005; 200 ng/ml: R2=0.28, p<0.05; 100 ng/ml: R2=0.41, p<0.005). 
 
The effects of methylphenidate and d-amphetamine were mimicked by 5-HT and 
blocked by a 5-HT antagonist 
The effects of d-amphetamine and methylphenidate on response amplitude were 
mimicked by the application of 1 ȝM 5-HT, which produced identical effects to the 
psychostimulants (R2=0.47, p<0.005; Figure 1D). In contrast, a higher concentration 
[10 ȝM] produced almost universal response suppression, but again this was more 
pronounced at low intensities (R2=0.73, p<0.001; Figure 1D).  The role of 5-HT in the 
actions of d-amphetamine and methylphenidate was confirmed by the fact that their 
effects were completely abolished by prior application the 5-HT receptor antagonist 
metergoline (10ȝM; Figure 2). In the presence of the antagonist, there was no 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 9
significant relationship between stimulation intensity and amplitude for either d-
amphetamine (R2=0.09, p>0.05) or methylphenidate (R2=0.12, p>0.05).  
 
The suppressive effects of d-amphetamine and methylphenidate are mediated 
pre-synaptically 
We used paired pulse stimulation to determine whether application of the psycho-
stimulants altered the probability of transmitter release and hence elicited effects 
through pre-synaptic actions. We found paired pulse depression (PPD) in the SC at all 
stimulus intensities under baseline conditions (high: t[2]=18.92, p<0.01; medium: 
t[3]=3.03, p<0.05; low: t[2]=18.92, p<0.001; Figure 3). In the presence of the two 
psychostimulants, PPD was significantly reduced at low intensities (d-amphetamine, 
t[5]=3.10, p<0.05; methylphenidate, t[5]=3.61, p<0.05), whilst unaffected at higher 
intensities (Figure 3), suggesting that response suppression at low intensities is 
caused, at least in part, by a reduction in release probability. 
 
To assess whether there was an additional post-synaptic component to the effects of 
d-amphetamine and methylphenidate on collicular responses, we examined the effects 
of these drugs on receptor-mediated subcomponents of the synaptic response, the 
contribution of which may differentially change if post-synaptic changes occur at the 
receptor level. Stimulation-induced SC responses are mediated by excitatory amino 
acids, with Į-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor 
activation dominating at high intensities and N-methyl-D-aspartate (NMDA) receptor 
activation at low (Figure 4). D-amphetamine and methylphenidate had no significant 
effect on the AMPA:NMDA ratio at low intensities (Figure 4B; AMPA:NMDA ratio 
pre-drug 0.48±0.13; d-amphetamine 0.65±0.07, t[4]=1.66, p>0.05; methylphenidate 
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0.84±0.22, t[3]=1.21, p>0.05), suggesting that post-synaptic changes at the receptor 
level had not taken place and that 5-HT mediated suppression of responses at low 
stimulus intensities was entirely due to pre-synaptic effects. However, at high 
intensities, in spite of a lack of change in release probability (see above), both drugs 
significantly reduced the AMPA:NMDA ratio (Figure 4B; AMPA:NMDA ratio pre-
drug 13.2±1.7; d-amphetamine 0.9±0.09, t[3]=7.06, p<0.05; methylphenidate 1.1±0.4, 
t[3]=6.82, p<0.05). The implied post-synaptic changes appear largely without 
consequence in our paradigm. 
 
Discussion 
D-amphetamine and methylphenidate increased the signal-to-noise ratio in the SC by 
differentially affecting the impact of weak and strong activations: suppressing the 
former and retaining the latter. The effects of d-amphetamine and methylphenidate on 
collicular responses could be abolished by a 5-HT antagonist and mimicked by 
application of a low concentration of 5-HT itself. Mediation by 5-HT is perhaps not 
surprising given the known pharmacology of psychostimulants and monoaminergic 
innervation of the SC. That is to say, it is widely accepted that d-amphetamine and 
methylphenidate act to increase synaptic levels of the monoamines dopamine, 
noradrenaline and 5-HT (Azzaro et al., 1974; Holmes & Rutledge, 1976; Kuczenski & 
Segal, 1989; Easton et al., 2007). There is extensive serotonergic innervation of the 
rat SC (Parent et al., 1981), compared with lesser dopaminergic or noradrenergic 
projections (Weller et al., 1987). This serotonergic innervation also preferentially 
targets superficial layers (Parent et al., 1981), meaning that 5-HT is the preeminent 
monoamine in the superficial layers of the SC. 
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Whilst there are no previous reports of 5-HT changing the signal-to-noise ratio in the 
SC, there is evidence of monoamines fulfilling that role elsewhere in the brain, the 
classic example being dopamine-induced increases in signal-to-noise ratio in the 
striatum and frontal cortex (Rolls et al., 1984; Kiyatkin & Rebec, 1996). 5-HT itself 
has also been shown to affect the signal-to-noise ratio, causing a reduction in the ratio 
in the somatosensory cortex (Waterhouse et al., 1986) and thalamus (Funke & Eysel, 
1993). However, previously reported examples of monoamine-mediated changes in 
the ratio, including those caused by 5-HT, have all arisen because of suppression of 
spontaneous background activity, producing a net increase in signal size. We however 
report a change in ratio due to an entirely novel mechanism: a change in the 
relationship between weak and strong signals (rather than signal and background), 
suppressing weak signals and retaining strong signals. 
 
The means by which a single neurotransmitter (5-HT) could produce differential 
effects on visual signals in the SC was uncertain; hence, we explored the mechanism 
further with a particular focus on whether the effects of 5-HT were pre- or post-
synaptically mediated. To achieve this, we examined the impact of d-amphetamine 
and methylphenidate on the AMPA and NMDA receptor-mediated components of the 
SC responses and collicular responses to paired pulses. In line with previous research 
(Platt & Withington, 1997), we found that paired pulse stimulation of the visual input 
to the SC resulted in depression of the response to the second pulse (PPD), indicating 
a decrease in transmitter release to this pulse. Under baseline conditions, this PPD 
was far greater in response to paired pulses of low intensity stimulation in contrast to 
those of medium and high intensity. Given the depressed response to the second pulse 
is normally associated with a lack of easily releasable transmitter following the 
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response to the initial pulse, it is likely that stimulating at medium or high intensities 
has the effect of mobilising some of the harder to release stores of transmitter 
(Zucker, 1989), thus overcoming the depressed response to the second pulse.  
 
If the psychostimulant-induced suppression of responses found at low intensities was 
due to pre-synaptic changes, it would be expected that PPD would be reduced in the 
presence of the drugs, indicating a decrease in transmitter release to the primary pulse 
(Rice & Cragg, 2004). This was indeed found to be the case, suggesting that the 
suppressive effects of d-amphetamine and methylphenidate to low stimulation 
intensities are at least partly mediated pre-synaptically. This conclusion is supported 
by the presence of pre-synaptic 5-HT receptors on optic afferents in the SC (Segu et 
al., 1986; Mooney et al., 1996), activation of which results in a decrease in release 
(Mooney et al., 1996).  
 
Further results suggest that the suppressive effects of d-amphetamine and 
methylphenidate to low stimulation intensities are exclusively mediated pre-
synaptically. Examining the effects of these drugs on receptor-mediated 
subcomponents of the synaptic response, we found that at low stimulation intensities, 
d-amphetamine and methylphenidate did not change the AMPD:NMDA ratio, 
suggesting that post-synaptic changes at the receptor level had not taken place and 
that 5-HT mediated suppression of responses at low stimulus intensities was entirely 
due to pre-synaptic effects. However, at high intensities, in spite of a lack of change in 
release probability (as revealed by the PPD work), both drugs significantly reduced 
the AMPA:NMDA ratio. This augmentation of the NMDA receptor-mediated 
component of the response appears to be a novel action for 5-HT, which suppresses 
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NMDA receptor-mediated responses elsewhere in the central nervous system 
(Marcoli et al., 1997; Liang et al., 1998). Although without consequence in our 
paradigm, it is possible that these post-synaptic excitatory amino acid receptor 
changes may produce response enhancements in other paradigms where relatively 
high levels of collicular activation are achieved, and may potentially underlie the 
amphetamine-related enhancements in collicular visual processing seen by Grasse et 
al. (1993; see Introduction).  
 
At a behavioural level, the effect of d-amphetamine and methylphenidate on the 
signal-to-noise ratio in the SC could explain how these drugs improve sustained 
attention (Mackworth, 1965; Elliott et al., 1997; Bizarro et al., 2004) and improve 
distractibility (Halliday et al., 1990; Brown & Cooke, 1994; Agmo et al., 1997; 
Spencer et al., 2001; Faraone et al., 2007). The SC is widely acknowledged to be 
important for the generation of saccades (Sparks, 1999), with superficial layer 
neurons responding more vigorously to a stimulus if it is the target for a saccade 
(Goldberg & Wurtz, 1972). In terms of recent conceptualisations of the manner in 
which bids for motor expression, by systems (like the colliculus) capable of 
specifying actions, are processed by the brain (Redgrave et al., 1999; Gurney et al., 
2001), enhanced activity can be seen as putting a stronger ‘bid’ into the central 
selection device, hypothesised to be the basal ganglia. In the case of the superficial 
layers of the SC, this can occur either via direct ascending projections to the thalamus 
and then forward to the neostriatum (McHaffie et al., 2005), or via a link in the deep 
layers of the SC (Lee et al., 1997), which also project to the thalamus (McHaffie et 
al., 2005). A stronger bid is more likely to win against competitors and generate a 
motor output (enabled through a reduction in tonic inhibition of the SC deep layers 
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arising from basal ganglia output structures, see Chevalier & Deniau, 1990) and hence 
an eye movement. By enhancing SC responses, the likelihood of eye movements 
could be increased. Conversely, by depressing responses in the SC, the likelihood of 
eye movements would be reduced. By effectively reducing responsiveness - bids - by 
weak stimuli, psychostimulants have the effect of biasing the system so that 
distractions only occur to particularly salient stimuli, thus leading to a reduction in 
overall distractibility and a correlative improvement in sustained attention. 
 
The results of the present study not only provide crucial insights into the mechanism 
by which d-amphetamine and methylphenidate decrease distractibility and improve 
sustained attention in normal subjects but also suggest that these drugs may at least in 
part act in the SC to the same effect in ADHD: a suggestion which is in line with 
evidence reviewed elsewhere (Overton, 2008) that the SC is dysfunctional in ADHD. 
Consistent with the possibility that the colliculus may be dysfunctional in the 
disorder, and that 5-HT induced modulation of the SC is therapeutically important, 5-
HT selective drugs, such as fluoxetine, appear to have therapeutic efficacy in ADHD 
(Barrickman et al., 1991; Gibson et al., 2006). Furthermore, ADHD patients have 
been reported to show alterations in 5-HT metabolism (Hoshino et al., 1985). If 
psychostimulants do achieve their therapeutic effects on distractibility by an action at 
the level of the SC, then the development of drugs which dampen stimulus-related 
activity in this region could represent an important novel path for the development 
non-addictive pharmacotherapies for ADHD. 
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Figure Legends 
 
Figure One: (A) Experimental paradigm showing stimulating (Stim) and recording 
(Rec) electrode positions (OT: optic tract, SGS, stratum griseum superficiale, SO 
stratum opticum, SGI, stratum griseum intermediale). (B) The effects of d-
amphetamine (900 ng/ml) and (C) methylphenidate (300 ng/ml) on collicular 
responses varied with stimulus intensity. Points below the dotted line indicate a 
decrease in response and points above indicate an increase. Insert images show typical 
traces for low and high stimulation intensities in the presence (blue=amphetamine, 
red=methylphenidate) and absence (black) of the psychostimulants. Similar effects 
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were found with a low concentration (dose) of 5-HT (1 ȝM), but a high concentration 
of 5-HT (10 ȝM) was universally depressant (D).  
 
Figure Two: In the presence of the 5-HT receptor antagonist metergoline (10ȝM), 
neither d-amphetamine (900ng/ml; A) nor methylphenidate (300ng/ml; B) had any 
effect on collicular responses elicited by optic tract stimulation. 
 
Figure Three (A) The paired pulse depression (PPD) evident in the SC at baseline was 
suppressed by methylphenidate (MPH; 300 ng/ml) and d-amphetamine (AMPH; 900 
ng/ml) at low stimulation intensities only: * p<0.05 vs MPH and AMPH. (B) Typical 
traces showing PPD for each of the three stimulation intensities and drug conditions.  
 
Figure Four (A) shows typical traces in response to high and low intensity stimulation 
during control (baseline) conditions and in the presence of an NMDA receptor 
antagonist (AP5, 10 ȝM) or an AMPA receptor antagonist (CNQX, 10 ȝM). (B) In the 
presence of methylphenidate (MPH; 300 ng/ml) and d-amphetamine (AMPH; 900 
ng/ml), the NMDA receptor-mediated component of the high intensity responses was 
significantly increased: * p<0.05 vs Control.  
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Supplementary Figure One: As with higher concentrations, lower concentrations of both 
d-amphetamine (300ng/ml, A; 600ng/ml; B) and methylphenidate (100ng/nl, C; 
200ng/ml, D) also altered collicular responses in a manner which was dependent on the 
stimulus intensity. 
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